Headline
The latest stories from AHA Today.
The Department of Health and Human Services announced in an email that it is planning an additional distribution of funds to hospitals that have been particularly affected by the increased burden of caring for those with COVID-19.
The Department of Health and Human Services announced that it will distribute $10 billion from the Public Health and Social Services Emergency Fund to hospitals that serve a disproportionate number of Medicaid patients or provide large amounts of uncompensated care.
The Internal Revenue Service issued a proposed rule implementing a provision of the Tax Cuts and Jobs Act of 2017 that imposed a 21% excise tax on certain executive compensation paid by tax-exempt organizations.
FDA released new guidance that expands for the duration of the COVID-19 emergency the availability and capability of non-invasive monitoring devices.
CMS released guidance for non-federal governmental plans implementing the Families First Coronavirus Response Act requirement to cover COVID-19 diagnostic testing and certain related items and services without cost-sharing, prior authorization or other medical management restrictions during the…
The Food and Drug Administration reissued emergency use authorizations that revise policy on the types of respirators that can be decontaminated for reuse.
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response shared resources for protecting community hospitals and providing care during civil unrest.
Eligible hospitals can apply through July 6 to participate in the Medicare Direct Contracting Model, which will offer two primary care payment options for hospitals beginning next April.
After losing 1.5 million jobs in April, the health care field added 312,000 jobs in May, increasing 2% to a seasonally adjusted 15.2 million, the Bureau of Labor Statistics reported.
The Food and Drug Administration released COVID-19 performance data for four more antibody test kits. The results come from the first collaboration between FDA, the National Institute of Health’s National Cancer Institute, Centers for Disease Control and Prevention and Biomedical Advanced Research…